MTND1P24

Across TCGA pan-cancer cohorts, MTND1P24 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MTND1P24 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MTND1P24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND1P24 expression acts as an unfavorable survival marker, although some lineages such as UCS and LIHC show a favorable association.

DLBC, OV, and BRCA are the cancer types where MTND1P24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	All	0.426	0.841	.018	63	view →
OV	OS	Quartile	IV	0.410	0.678	.017	50	view →
BRCA	DFS	Tertile	II,III,IV	0.790	0.894	.017	15	view →
UCS	OS	Tertile	III,IV	1.000	0.301	.047	12	view →
GBM	DFS	Tertile	All	0.159	0.316	.045	9	view →
CHOL	OS	Tertile	All	0.155	0.725	.029	9	view →
LIHC	DFS	Tertile	All	1.000	0.499	.017	9	view →
ESCA	OS	Tertile	All	0.780	0.631	.029	8	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MTND1P24–DLBC (DFS)

Open the DLBC breakdown →